Cyclacel Pharmaceuticals, Inc. (CYCCP)
CYCCP Stock Price Chart
Explore Cyclacel Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze CYCCP price movements and trends.
CYCCP Company Profile
Discover essential business fundamentals and corporate details for Cyclacel Pharmaceuticals, Inc. (CYCCP) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Nov 2005
Employees
12.00
Website
https://www.cyclacel.comCEO
Sing Ee Wong
Description
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-like kinase inhibitor program, which is in Phase 1/2 clinical trial for the treatment of advanced leukemias and solid tumors. Its development programs also comprise Sapacitabine, a novel nucleoside analog that is orally available prodrug of CNDAC, which is in Phase 1/2 clinical trials to treat acute myeloid leukemia and myelodysplastic syndrome; and seliciclib, a CDK inhibitor that is in Phase 2 investigator-sponsored trials (IST) for Cushing's disease, as well as in Phase 1/2 IST for the treatment for advanced rheumatoid arthritis. The company has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. Cyclacel Pharmaceuticals, Inc. is headquartered in Berkeley Heights, New Jersey.
CYCCP Financial Timeline
Browse a chronological timeline of Cyclacel Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 10 Nov 2025
Earnings released on 13 Aug 2025
EPS came in at -$0.83 surpassing the estimated -$72.00 by +98.84%.
Stock split effective on 7 Jul 2025
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Dividend declared on 3 Jun 2025
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 1 Aug 2025.
Earnings released on 15 May 2025
EPS came in at -$0.00 surpassing the estimated -$69.60 by +100.00%.
Dividend declared on 19 Apr 2025
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 1 May 2025.
Earnings released on 2 Apr 2025
EPS came in at -$0.34 surpassing the estimated -$4.64 by +92.58%, while revenue for the quarter reached -$35.00K , missing expectations by -450.00%.
Earnings released on 12 Nov 2024
EPS came in at -$0.91 , while revenue for the quarter reached $10.00K , meeting expectations.
Earnings released on 14 Aug 2024
EPS came in at -$1.80 , while revenue for the quarter reached $4.00K .
Earnings released on 14 May 2024
EPS came in at -$2.27 , while revenue for the quarter reached $29.00K .
Earnings released on 19 Mar 2024
EPS came in at -$6.17 , while revenue for the quarter reached $31.00K .
Dividend declared on 12 Jan 2024
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 1 Feb 2024.
Earnings released on 8 Jan 2024
EPS came in at -$7.23 , while revenue for the quarter reached $16.00K .
Earnings released on 29 Nov 2023
EPS came in at -$8.87 .
Dividend declared on 6 Sept 2023
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 1 Nov 2023.
Earnings released on 10 Aug 2023
EPS came in at -$6.51 , while revenue for the quarter reached $373.00K .
Dividend declared on 13 Jun 2023
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 1 Aug 2023.
Earnings released on 11 May 2023
EPS came in at -$6.94 .
Dividend declared on 8 Mar 2023
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 1 May 2023.
Dividend declared on 6 Dec 2022
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 1 Feb 2023.
Earnings released on 10 Nov 2022
EPS came in at -$2.68 .
Dividend declared on 7 Sept 2022
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 1 Nov 2022.
Earnings released on 11 Aug 2022
EPS came in at -$2.41 .
Dividend declared on 14 Jun 2022
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 1 Aug 2022.
Earnings released on 12 May 2022
EPS came in at -$2.16 .
Earnings released on 30 Mar 2022
EPS came in at -$2.78 .
Dividend declared on 16 Mar 2022
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 1 May 2022.
Dividend declared on 13 Dec 2021
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 1 Feb 2022.
Earnings released on 12 Nov 2021
EPS came in at -$2.62 .
Dividend declared on 8 Sept 2021
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 1 Nov 2021.
Earnings released on 12 Aug 2021
EPS came in at -$2.70 .
Dividend declared on 22 Jun 2021
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 1 Aug 2021.
Earnings released on 14 May 2021
EPS came in at -$1.83 .
Dividend declared on 25 Mar 2021
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 1 May 2021.
Earnings released on 1 Mar 2021
EPS came in at -$1.47 , while revenue for the quarter reached $5.88 .
Dividend declared on 11 Dec 2020
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 1 Feb 2021.
Earnings released on 12 Nov 2020
EPS came in at -$1.19 .
Dividend declared on 10 Sept 2020
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 1 Nov 2020.
CYCCP Stock Performance
Access detailed CYCCP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.